tiprankstipranks
Trending News
More News >
Mabpharm Limited (HK:2181)
:2181
Hong Kong Market

Mabpharm Limited (2181) Income Statement

Compare
0 Followers

Mabpharm Limited Income Statement

Last quarter (Q2 2025), Mabpharm Limited's total revenue was ¥274.18M, an increase of 522.86% from the same quarter last year. In Q2, Mabpharm Limited's net income was ¥2.90M. See Mabpharm Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 258.23M¥ 87.16M¥ 55.92M¥ 82.88M¥ 0.00
Gross Profit
¥ 219.39M¥ 75.24M¥ 40.54M¥ 66.11M¥ 0.00
Operating Expenses
¥ 339.07M¥ 277.22M¥ 266.79M¥ 363.63M¥ 186.21M
Depreciation and Amortization
¥ 51.86M¥ 60.70M¥ 51.55M¥ 43.88M¥ 16.28M
EBITDA
¥ -67.81M¥ -139.08M¥ -152.08M¥ -245.46M¥ -169.93M
Operating Income
¥ -119.67M¥ -201.98M¥ -226.25M¥ -297.52M¥ -186.21M
Other Income/Expenses
¥ -8.28M¥ -7.37M¥ 15.43M¥ 5.78M¥ 1.58M
Pretax Income
¥ -127.95M¥ -209.36M¥ -210.82M¥ -291.74M¥ -184.63M
Net Income
¥ -127.95M¥ -209.36M¥ -210.62M¥ -291.74M¥ -188.57M
Per Share Metrics
Basic EPS
¥ -0.03¥ -0.05¥ -0.05¥ -0.07¥ -0.04
Diluted EPS
¥ -0.03¥ -0.05¥ -0.05¥ -0.07¥ -0.04
Weighted Average Shares Outstanding
4.12B 4.12B 4.12B 4.12B 4.12B
Weighted Average Shares Outstanding (Diluted)
4.12B 4.12B 4.12B 4.12B 4.12B
Currency in CNY

Mabpharm Limited Earnings and Revenue History